Priv.-Doz. Dr. med. Martin Neumann

Facts

Phone: +49-431-500-22555
E-Mail: M.Neumann@uksh.de
Website:
www.uksh.de/med2-kiel
Affiliations: Clinic for Internal Medicine II, Hematology and Oncology / University Medical Center Schleswig-Holstein, Campus Kiel
Address: Arnold-Heller-Str. 3, Bldg L, 24105 Kiel

Curriculum vitae

Education/Training

2015Medical Board Examination in Hematology and Oncology
2012Medical Board Examination in Internal Medicine
2005Doctoral thesis, LMU Munich
2004Medical exam, TU Munich
2000-2004Clinical Studies, Medical School, TU Munich 
1998-2000Preclinical Studies Medical School LMU Munich
1998Diploma in physics

Research Experience/Academic Appointments

Since 2019Attending physician, UKSH Kiel, Clinic for Internal Medicine II, Hematology and Oncology (directress: Prof. Dr. C. D. Baldus)
2017-2018Attending physician, Charité – University Hospital Berlin, Campus Benjamin Franklin Hematology and Oncology (acting directress: Prof. Dr. C. D. Baldus)
2016Venia Legendi, Internal Medicine, Charité – University Hospital Berlin, „Molecular characterization of T cell acute lymphoblastic leukemia for treatment optimization“
2005-2018Residency/Fellowship, Department of Hematology and Oncology, Charité, Berlin
2001-2005Doctoral thesis at the Alfred Butenandt Institute, AG Becker, Munich
Fields of InterestTranslational research in acute leukemia, molecular characterization of acute lymphoblastic leukemia with prognostic and predictive correlation, clonal hematopoiesis

Important Scientific Prizes/Functions

2019ASH Abstract Reviewer
2015ASH Abstract Achievement Award
2013ASH Abstract Achievement Award
Since 1993Studienstiftung des Deutschen Volkes

Research groups

Z

Clinical translation

Molecular guided experimental treatments in patients with relapsed/refractory lymphoid malignancies – Project Z-Platform

Project-related publications

Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols.

Neumann M, Beder T, Bastian L, Hänzelmann S, Bultmann M, Wolgast N, Hartmann A, Trautmann H, Ortiz-Tanchez J, Schlee C, Schroeder M, Fransecky L, Vosberg S, Fiedler W, Alakel N, Heberling L, Kondakci M, Starck M, Schwartz S, Raffel S, Müller-Tidow C, Schneller F, Reichle A, Burmeister T, Greif PA, Brüggemann M, Gökbuget N, Baldus CD

PubMed (PMID: 38744920)
Leukemia
2024
P1, P3, P4, INF, Z

The Gene Expression Classifier ALLCatchR Identifies B-cell Precursor ALL Subtypes and Underlying Developmental Trajectories Across Age

Beder T, Hansen BT, Hartmann AM, Zimmermann J, Amelunxen E, Wolgast N, Walter W, Zaliova M, Antić Ž, Chouvarine P, Bartsch L, Barz MJ, Bultmann M, Horns J, Bendig S, Kässens J, Kaleta C, Cario G, Schrappe M, Neumann M, Gökbuget N, Bergmann AK, Trka J, Haferlach C, Brüggemann M, Baldus CD, Bastian L.

PubMed (PMID: 37645423)
HemaSphere
2023
P1, P3, P4, Z, INF

Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL.

Bastian L, Beder T, Barz MJ, Bendig S, Bartsch L, Walter W, Wolgast N, Brändl B, Rohrandt C, Hansen BT, Hartmann AM, Iben K, Das Gupta D, Denker M, Zimmermann J, Wittig M, Chitadze G, Neumann M, Schneller F, Fiedler W, Steffen B, Stelljes M, Faul C, Schwartz S, Müller FJ, Cario G, Harder L, Haferlach C, Pfeifer H, Gökbuget N, Brüggemann M, Baldus CD.

PubMed (PMID: 38153913)
Blood
2023
P1, P3, P4, INF, Z

UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment

Bastian L, Hartmann AM, Beder T, Hänzelmann S, Kässens J, Bultmann M, Hoeppner MP, Franzenburg S, Wittig M, Franke F, Nagel I, Spielmann M, Reimer N, Busch H, Schwartz S, Steffen B, Viardot A, Döhner K, Kondakci M, Wulf G,  Wendelin K, Renzelmann A, Kiani A, Trautmann H, Neumann M, Gökbuget N, Brüggemann M, Baldus CD

PubMed (PMID: 35397658)
Leukemia
2022
P1, P3, P4, Z

Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures

Schroeder MP, Bastian L, Eckert C, Gökbuget N, James AR, Tanchez JO, Schlee C, Isaakidis K, Häupl B, Baum K, Migueles Lozano OA, Kouidri K, Pan KT, Urlaub H, Schwartz S, Burmeister T, von Stackelberg A, Hoelzer D, Pfeiffer H, Rieger MA, Göllner S, Oellerich T, Horstmann M, Schrappe M, Wolf J, Kirschner-Schwabe R, Brüggemann M, Müller-Tidow C, Serve H, Neumann M, Baldus CD

PubMed (PMID: 30862934)
Sci Rep
2019
P1, P3, P4, Z

Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures

Schroeder MP, Bastian L, Eckert C, Gökbuget N, James AR, Tanchez JO, Schlee C, Isaakidis K, Häupl B, Baum K, Migueles Lozano OA, Kouidri K, Pan KT, Urlaub H, Schwartz S, Burmeister T, von Stackelberg A, Hoelzer D, Pfeiffer H, Rieger MA, Göllner S, Oellerich T, Horstman M, Schrappe M, Wolf J, Kirschner-Schwabe R, Brüggemann M, Müller-Tidow C, Serve H, Neumann M, Baldus CD

PubMed (PMID: 30862934)
Sci Rep
2019

Participating Institutes